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Abstract
Background
Spontaneous intracerebral haemorrhage is a devastating form of stroke and its incidence
increases with age. Obtaining brain tissue following intracerebral haemorrhage helps to
understand its cause. Given declining autopsy rates worldwide, the feasibility of establish-
ing an autopsy-based collection and its generalisability are uncertain.
Methods
We used multiple overlapping sources of case ascertainment to identify every adult diag-
nosed with intracerebral haemorrhage between 1st June 2010-31st May 2012, whilst resi-
dent in the Lothian region of Scotland. We sought consent from patients with intracerebral
haemorrhage (or their nearest relative if the patient lacked mental capacity) to conduct a
research autopsy.
Results
Of 295 adults with acute intracerebral haemorrhage, 110 (37%) could not be approached to
consider donation. Of 185 adults/relatives approached, 91 (49%) consented to research
autopsy. There were no differences in baseline demographic variables or markers of intra-
cerebral haemorrhage severity between consenters and non-consenters. Adults who died
and became donors (n = 46) differed from the rest of the cohort (n = 249) by being older
(median age 80, IQR 76–86 vs. 75, IQR 65–83, p = 0.002) and having larger haemorrhages
(median volume 23ml, IQR 13–50 vs. 13ml, IQR 4–40; p = 0.002).
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Conclusions
Nearly half of those approached consent to brain tissue donation after acute intracerebral
haemorrhage. The characteristics of adults who gave consent were comparable to those in
an entire community, although those who donate early are older and have larger haemor-
rhage volumes.
Introduction
Spontaneous intracerebral haemorrhage (ICH) is a devastating form of stroke which carries a
one month case fatality of approximately 42%[1] and has an increasing incidence with age.
Given the ageing population in the UK and other developed countries,[2] ICH incidence is
likely to increase.
Although investigations may help to identify a specific ICH cause such as a tumour (second-
ary ICH), ~80% ICHs do not have an apparent cause (so called ‘primary ICH’) and are attrib-
uted to small vessel vasculopathies on the basis of a patient’s clinical risk factors and
radiological features of the ICH.[3] Examination of brain tissue may help us to understand
more about ICH cause, in particular the contribution of small vessel vasculopathies, which can
still only be diagnosed with certainty using pathological specimens.
Research using brain tissue samples has been hampered by declining post-mortem examina-
tion rates,[4] various organ retention scandals and an incomplete understanding of factors
which may influence consent.[5] Studies of organ donation for transplant have identified the
timing of the request and whether the request is made ‘collaboratively’ by both the organ dona-
tion and clinical teams as being predictors of obtaining consent.[6] A recent systematic review
[5] identified eleven studies of brain donation for research but no previous studies in adults
with stroke. The heterogeneity of previous studies both in terms of their donor populations
and mode of seeking consent precludes firm conclusions but demographic factors such as
donor age, sex, marital status, level of education and social class do not seem to influence
consent.
In a community-based study of brain tissue donation from adults dying after ICH, we
sought to ascertain: a) the proportion giving consent, b) whether any characteristics of partici-
pants, their ICH or the consent process were associated with giving consent and c) whether
adults approached to give consent, those who consented and those who eventually became
brain donors were representative of the entire cohort of patients with ICH.
Methods
Community-based inception cohort study of ICH
The Lothian Audit of the Treatment of Cerebral Hemorrhage (LATCH) ascertained all resi-
dents in the Lothian Health board region of Scotland (mid-2010 population aged16 years
was 695,335) who were aged16 years at the time they were diagnosed with first-ever or recur-
rent ICH confirmed by brain imaging or pathology between 1st June 2010 and 31st May 2012
inclusive. We excluded adults with exclusively extra-axial intracranial haemorrhage or ICH
definitely attributable to trauma or hemorrhagic transformation of an ischaemic stroke.[7]
We identified incident ICH cases using multiple overlapping sources of case ascertainment.
[7] The NHS Lothian Caldicott Guardian approved LATCH. Patients in NHS Lothian were
informed about the use of their data for audit, and information leaflets about LATCH were
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distributed to inform patients and their carers about their right to opt out. Analyses of an anon-
ymised dataset, extracted from the audit database held on NHS and University servers, did not
require research ethics committee approval.
Consent for brain tissue donation
Patients with ICH ascertained by LATCH had the opportunity to consent to participate in the
Lothian IntraCerebral Haemorrhage, Pathology, Imaging and Neurological Outcome (LINCH-
PIN) study, a prospective community-based research study examining the causes of ICH using
research autopsy in case of death. If the patient lacked mental capacity as defined by the Adults
with Incapacity (Scotland) Act 2000, we sought consent for brain tissue donation from their
nearest relative or legal representative in accordance with the statutory requirements of the
Human Tissue (Scotland) Act 2006 which requires consent to be sought before the use of a
deceased person’s organs, tissues or cells for medical research.
We sought consent in person, tailoring information to the participant’s wishes. We provided
participants or their relatives with an information leaflet detailing the autopsy process and dis-
cussed both generic consent issues (such as the voluntary nature of participation and confi-
dentiality) and information regarding the process of brain donation on many occasions if
required to ensure that all concerns were addressed.[5] We sought written informed consent
from the donor or their next-of-kin for one centimetre cubed brain tissue samples to be taken
from all lobes of the brain, the cerebellum and brainstem to be used for research purposes, with
the remainder of the brain returned to the donor’s body. The Scotland A Research Ethics Com-
mittee approved the study (10/MRE00/23).
Clinical information
We collected clinical variables by interviewing patients or their families at the time of presenta-
tion and reviewing primary care and hospital records. We classified ethnicity as either white or
non-white and level of education as either basic (school only) or further/higher (college,
apprenticeships or university).
We assessed socioeconomic status using the Scottish Index of Multiple Deprivation (http://
www.scotland.gov.uk/Topics/Statistics/SIMD/BackgroundMethodology; 2012) which ranks
regions by postcode from the most deprived (rank one) to the least deprived (rank 20) using a
combination of 38 indicators across the following domains: income, employment, health, edu-
cation, skills and training, housing, geographic access and crime.
We defined ICH location as either ‘lobar’ or ‘non-lobar’. At least one experienced consultant
neuroradiologist reviewed diagnostic brain imaging and classified ICH location as ‘non-lobar’
if an adult had a single infratentorial ICH (located in the brainstem or cerebellum), a single
supratentorial deep ICH (located in the basal ganglia, internal or external capsule or thalamus
without extension to a lobar area), or multiple ICHs in solely non-lobar locations (either supra-
tentorial deep or infratentorial). All other ICHs were ‘lobar’.
Statistical analysis
Based upon previous studies of consent for brain tissue donation,[5] we compared demo-
graphic, clinical and radiological characteristics in adults who a) were approached to consider
brain donation vs. those who were not, b) in those who consented to brain donation vs. those
declined, c) in those who consented vs. the remainder of the cohort and d) in donors vs. the
remainder of the cohort. We used parametric statistics when characteristics conformed to a
normal distribution and non-parametric statistics when they did not.
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For adults who underwent brain imaging (and were not diagnosed at autopsy) we calculated
ICH volume using the first CT brain scan after the adult’s symptom onset using the ABC/2
method.[8] We documented contemporaneously the reason(s) cited by participants or their
nearest relative for giving or declining brain donation.
From existing knowledge from studies of organ donation for transplantation on features of
the consent process which may influence whether consent is obtained,[6] we selected a priori
three variables to compare between those who consented and those who declined: whether a
member of the clinical team or the research team first discussed post-mortem examination, the
interval between the date of the ICH and the date brain donation was first discussed, and
whether consent was sought from the patient or their nearest relative.
Results
Of 295 adults with spontaneous primary ICH (who were eligible for brain donation) from 1st
June 2010-31st May 2012, 110 (37%) were not approached, leaving 185 adults of whom 91
(49%; 95% CI 42–56%)) consented to brain tissue donation in case of death (Fig 1). The most
frequent reason that participants were not approached was that they had died before being
ascertained or before brain tissue donation was discussed (n = 61; 55%). 20 adults (18%) were
ascertained late (at least two months after the date of their ICH) when we no longer considered
it appropriate to approach participants to request brain donation.
Approached vs. not approached to consider brain donation
Adults who were not approached had a lower socioeconomic status but other baseline demo-
graphic characteristics were similar in both groups (Table 1). Adults not approached had sig-
nificantly lower conscious levels on admission with larger ICHs which were more likely to
rupture into the ventricles.
Consented to brain donation vs. declined consent
Baseline demographic and clinical variables and features of the consent process were similar in
those who consented to brain donation vs. those who declined (Table 2).
Consented to brain donation vs. the remainder of the cohort
Adults who consented had a higher socioeconomic status in comparison to the rest of the
cohort but there were no other differences in either demographic or clinical characteristics
(Table 3).
Reasons cited for giving and declining consent for brain donation
Participants or their nearest relatives cited a median number of one theme (IQR 1–1) both
when consenting to, and declining, brain donation (Tables 4 and 5). The most frequent reason
given was the potential benefit as a result of their donation to others with the same condition
(Table 4). The most frequent reason given for declining to participate was that the person
asked did not feel able to make a decision (Table 5).
Donors vs. the rest of the cohort
Donors were older and had larger ICHs in comparison to the remainder of the cohort
(Table 6). 14 donors survived for longer than three months after their ICH. In a sensitivity
analysis restricted to donors who died within three months of their ICH the results were
unchanged.
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Discussion
Main findings
In a prospective, community-based inception cohort study, 49% of adults with ICH or their rel-
atives who were approached, later consented to donate brain tissue at a research autopsy.
Adults who were approached had a higher socioeconomic status and less severe ICHs than
those not approached. There were no significant differences between those who consented and
those who declined brain donation. Those who consented had a higher socioeconomic status
in comparison to the remainder of the cohort. Donors were older and had larger ICHs in com-
parison to the remainder of the cohort.
Fig 1. Flowchart of adults with spontaneous ICH eligible to donate brain tissue from 1st June 2010-31st
May 2012.
doi:10.1371/journal.pone.0135043.g001
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Strengths of the study
To the best of our knowledge, this is the first study to report the proportions consenting to
brain donation for research purposes in a population-based cohort of participants with any
form of stroke.
The population-based design with comprehensive case ascertainment permits an evaluation
of the representativeness of those who were approached to consider brain donation, those who
consented and those who eventually became brain donors in comparison to the remainder of
Table 1. Baseline characteristics of adults with spontaneous ICH approached and not approached to consider brain donation.
Approached to consider brain donation
(n = 185)
Not approached to consider brain donation
(n = 110)
p
value
Sex male, (%) 90 (49) 51 (46) 0.70
Age (years); median (IQR) 77 (68–82) 77 (65–85) 0.32
Ethnicity non-white, (%) 7 (4) 1 (1) 0.27
Socio-economic status* (postcode rank) 13 (7–18) 10 (6–16) 0.03
Admission GCS score**; median (IQR) 14 (12–15) 10 (4–15) <0.001
Mean arterial pressure*** (mmHg) mean
(SD)
115 (25) 119 (29) 0.22
Lobar ICH location 99 (64) 56 (51) 0.67
Intraventricular extension^ 74 (40) 67 (61) <0.001
ICH volume^ (ml); median (IQR) 14 (5–30) 21 (5–58) 0.04
*Scottish index of multiple deprivation categories (2012); higher postcode rank indicates lower deprivation index; missing in two cases
**Glasgow Coma Scale score—missing in nine cases; four of whom were not admitted to hospital
***missing in 22 cases
^not applicable in ﬁve cases in which the diagnosis was conﬁrmed at post-mortem examination
doi:10.1371/journal.pone.0135043.t001
Table 2. Demographic and clinical variables and characteristics of the consent process in adults who give consent to brain tissue donation and
those who decline donation.
Consented to brain donation
(n = 91)
Declined brain donation
(n = 94)
p
value
Non-modiﬁable patient characteristics
Sex male, (%) 48 (53) 42 (45) 0.27
Age (years); median (IQR) 76 (69–84) 77 (67–82) 0.33
Ethnicity non-white, (%) 1 (1) 6 (6) 0.12
Socio-economic status* 14 (7–18) 12 (7–17) 0.18
Donor education**; further or higher, (%) 24 (26) 21 (22) 0.50
Non-modiﬁable ICH characteristics
Admission Glasgow Coma Scale score; median (IQR) 14 (11–15) 14 (13–15) 0.04
Intraventricular extension*** Yes (n, %) 39 (43) 35 (37) 0.40
ICH volume***(ml); median (IQR) 15 (5–30) 12 (5–30) 0.28
Modiﬁable characteristics of the consent process
Approached by clinical team and researcher (vs. researcher alone) 8 (9) 4 (4) 0.21
Interval between date of ICH and date post-mortem examination
discussed^ (days; median (IQR))
4 (2–12) 5 (2–14) 0.99
Approached nearest relative (vs. participant) 61 (67) 60 (55) 0.65
*missing in two cases
** missing in 22 cases
***not applicable in one case of ICH which was diagnosed at post-mortem examination
^missing in four cases
doi:10.1371/journal.pone.0135043.t002
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the cohort. Participants were well phenotyped since the clinical history was ascertained pro-
spectively prior to the outcome (obtaining consent) and ICH-related variables were ascertained
blind to the outcome. There were few differences between those who consented, donors and
the rest of the cohort and differences were predominantly attributable to disease severity.
These may disappear when those who consented die after milder ICHs.
Weaknesses of the study
The study took place in a predominantly white population in South East Scotland so we could
not examine the role of ethnicity and differing cultural beliefs on donation. Although partici-
pants may be more likely to consent to retention of tissue samples rather than their whole
brain,[9] we were unable to explore this in our cohort. ICH has a high early case fatality so we
were unable to approach ~ one third of adults who had more extensive ICHs in comparison to
those approached, the majority of whom had died either before ascertainment or before brain
tissue donation could be discussed. We did not explore demographic or cultural factors per-
taining to nearest relatives although these may influence participants’ perceptions of brain
donation. In addition, the study was largely quantitative in nature and studying the influence
of cultural beliefs and personal experience on donation is likely to be more suited to qualitative
methodologies.
Table 3. Demographic and clinical characteristics in those who consented to brain donation vs. remainder of the cohort.
Consented to brain donation (n = 91) Did not consent to brain donation (n = 204) p value
Sex male, (%) 48 (53) 93 (46) 0.25
Age (years); median (IQR) 76 (69–84) 77 (67–83) 0.78
Ethnicity non-white, (%) 1 (1) 7 (3) 0.45
Socio-economic status (postcode)* 14 (7–18) 11 (6–16) 0.03
Admission GCS score** median (IQR) 14 (11–15) 14 (8–15) 0.10
Mean arterial pressure*** (mmHg) mean (SD) 116 (23) 116 (28) 0.97
Lobar ICH location 54 (59) 101 (50) 0.12
Intraventricular extension^ 39 (43) 102 (50) 0.23
ICH volume^ (ml);median (IQR) 15 (5–30) 15 (5–42) 0.84
*missing in two cases
**Glasgow Coma Scale score—missing in nine cases; four of whom were not admitted to hospital
***missing in 22 cases
^not applicable in ﬁve cases in which the diagnosis was conﬁrmed at post-mortem examination
doi:10.1371/journal.pone.0135043.t003
Table 4. Reasons given for consent to brain donation among 91 consenters.
Reasons given for donation (most common ﬁrst) n (%)
Potential beneﬁt to others with the same condition 52 (57)
Wished to participate in a research study 24 (26)
Perception of body as merely a physical shell 10 (11)
Offer an explanation for the intracerebral haemorrhage 5 (5)
Consistent with prior wish to donate body to medical science 5 (5)
Wish to repay medical care provided 4 (4)
No objection to research post-mortem examination 2 (2)
Potential beneﬁt to patient from participation in a research study 2 (2)
No reason given 2 (2)
doi:10.1371/journal.pone.0135043.t004
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Comparison with other studies
The proportion of adults consenting to brain tissue donation in our study is comparable to
other studies of brain tissue donation which have taken place predominantly in the setting of
chronic diseases and healthy populations. Although two studies have reported much higher
consent proportions,[9,10] one of these studies predated the organ retention scandals of the
mid-1990’s (that may have contributed to a subsequent decline in post-mortem examinations)
[10] and the second study was conducted in the setting of sudden death[9] when a legal post-
mortem examination is mandated to establish the cause of death.
In our study, there was no difference in demographic variables between those who con-
sented and those who declined (apart consenters having a higher socioeconomic status, which
may relate to the characteristics of the catchment population of the hospital at which the
research team was based); other studies of brain donation have not shown any influence of
donor sex, age, level of education or socioeconomic status on the decision to consent.[5] There
was no difference between those who consented and those who declined brain donation
regarding the person making the approach or the timing of it. Since a joint approach by the
clinical and research teams was rare in this cohort, it may be that there was insufficient power
to demonstrate a difference. One study of sudden death reported that the longer the interval
between death and the approach for brain donation, the more likely that consent would be
given[11] but we did not find this in our cohort.
As in our cohort, prospective donors have commonly reported altruistic motivations includ-
ing a desire to help others[10–15] or support research [9,13,15–17] in their decision to donate.
The most frequently cited reason for not giving consent in our cohort was that donors or their
nearest relatives felt unable to make a decision, which was related in part to the distress caused
by a diagnosis of ICH and a lack of clarity regarding what the donor’s wishes would have been.
This has not been cited in other studies of brain donation which have frequently been con-
ducted in either healthy participants or those with chronic neurological diseases when the deci-
sion to donate does not usually have to be made rapidly or unexpectedly.
Table 5. Reasons given for declining brain donation among 94 decliners.
Reasons given for refusal to consent n (%)
Nearest relative unable to decide 17 (18)
Did not know what the potential donor’s wishes would be 7 (8)
too upset by diagnosis of intracerebral haemorrhage 5 (5)
No reason given 5 (5)
Did not wish to be involved in a research study 13 (14)
Brain donation is ‘too invasive’ or ‘not something they wished to put their next-of-kin through’ 13 (14)
Consent was incompatible with previously expressed wishes 9 (10)
Conﬂict in family regarding post-mortem examination decision 9 (10)
Patient’s deteriorating condition or other comorbidities 6 (6)
Consent was incompatible with spiritual or religious beliefs 5 (5)
Dislike the idea of brain tissue donation 4 (4)
Autopsy not considered because thought to be synonymous with death 2 (2)
Concerns regarding autopsy procedure or disﬁgurement 2 (2)
Dissatisfaction with medical care 1 (1)
Dissatisfaction with previous discussion regarding organ donation 1 (1)
No reason given 15 (16)
doi:10.1371/journal.pone.0135043.t005
Consent for Brain Tissue Donation after ICH
PLOSONE | DOI:10.1371/journal.pone.0135043 August 24, 2015 8 / 11
Meaning of the study
An ongoing dilemma is how to increase the number of brains donated for research, a priority
acknowledged by BrainNet Europe and the UKMedical Research Council.[18] This study
demonstrates the feasibility of seeking consent for brain donation in acute neurological diseases
like ICH and forming a reasonably generalisable brain bank.
Although reasons for refusing consent which were likely irreversible predominated in our
cohort, a modifiable reason was not knowing what the participant’s wishes would have been. It
is essential to increase public awareness of organ donation for for both research and transplan-
tation with the aim of empowering people to reach their own decisions and communicate this
to relatives when they still have the mental capacity to do so.[19]
The lack of association between demographic characteristics and consent in this and other
studies[5] suggests that deciding whether to consent may be related to personal beliefs and
unquantifiable aspects of the consent process. Researchers or clinicians should avoid presum-
ing on the basis of demographic variables that either consent will not be obtained or asking will
cause upset. [18,20]
Future directions
We will re-assess the generalisability of this brain bank when more consenters die long after
milder ICHs. Future studies should examine brain donation in different populations for other
neurological diseases. Qualitative studies should explore the influence of personal beliefs and
experiences on consent, including factors which are difficult to measure quantitatively such as
the expertise and interpersonal skills of the person seeking consent and the donor’s perceived
satisfaction with clinical care.[6] Nearest relatives’ experiences of the consent and donation
process could help assess whether their expectations were met, whether they had any regrets
regarding donation and any improvements that could be made. Ultimately, this will be essen-
tial to ensure that brain banks are adequately representative of the neurological diseases that
are set to become more common in an ageing population.
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